|   | 
        Survived (%) | 
        Died (%) | 
        p value | 
       
      
        | Diagnosis : Medical | 
        163 (68%) | 
        76 (32%) | 
        0.02 | 
       
      
        | Surgical | 
        72 (82%) | 
        16 (18%) | 
          | 
       
      
        | Troponin Peak < 0.15 mcg/L | 
        90 (74%) | 
        32 (26%) | 
        0.0006 | 
       
      
        | > 0.15 mcg/L | 
        48 (51%) | 
        46 (49%) | 
          | 
       
      
        | Diabetes : No | 
        195 (71%) | 
        78 (29%) | 
        0.86 | 
       
      
        | Yes | 
        45 (73%) | 
        17 (27%) | 
          | 
       
      
        | Heart Disease : No | 
        211 (73%) | 
        80 (27%) | 
        0.37 | 
       
      
        | Yes  | 
        29 (66%) | 
        15 (34%) | 
          | 
       
      
        | Statin Use : No | 
        199 (72%) | 
        79 (28%) | 
        0.55 | 
       
      
        | Yes | 
        40 (71%) | 
        16 (29%) | 
          | 
       
      
        | ACEI Use:No | 
        198 (74%) | 
        70 (26%) | 
        0.05 | 
       
      
        | Yes | 
        40 (62%) | 
        25 (38%) | 
          | 
       
      
        | ASA Use: No | 
        201 (72%) | 
        79 (28%) | 
        0.71 | 
       
      
        | Yes | 
        36 (67%) | 
        16 (33%) | 
          | 
       
      
        | Beta Blocker Use: No | 
        196 (72%) | 
        78 (28%) | 
        0.96 | 
       
      
        | Yes | 
        42 (71%) | 
        17 (29%) | 
          | 
       
      
        | EKG Abnormalities: No | 
        61 (74%) | 
        21 (26%) | 
        0.74 | 
       
      
        | Yes | 
        86 (72%) | 
        33 (28%) | 
          | 
       
      
        | MI* : No | 
        215 (73%) | 
        80 (27%) | 
        0.14 | 
       
      
        | Yes | 
        24 (62%) | 
        15 (38%) | 
          | 
       
      
        | Sex : Male | 
        131 (72%) | 
        52 (28%) | 
        0.98 | 
       
      
        | Female | 
        109 (72%) | 
        43 (28%) | 
          | 
       
      |